| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 2001 |
The global tuberculosis situation and the inexorable rise of drug-resistant disease
|
Marais, Ben J.
|
|
2016
|
154-155 |
C |
p. 3-9
7 p.
|
artikel
|
| 2002 |
The good and the bad collagens of fibrosis – Their role in signaling and organ function
|
Karsdal, M.A.
|
|
2017
|
154-155 |
C |
p. 43-56
|
artikel
|
| 2003 |
The hepatic lipidome: From basic science to clinical translation
|
ten Hove, Marit
|
|
|
154-155 |
C |
p. 180-197
|
artikel
|
| 2004 |
The immunostimulatory nature of mRNA lipid nanoparticles
|
Sharma, Preeti
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2005 |
The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand
|
Clogston, Jeffrey D.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2006 |
The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery
|
Deruyver, Laura
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2007 |
The integration of hyperthermia and drug delivery
|
Dunne, Michael
|
|
|
154-155 |
C |
p. 1-2
|
artikel
|
| 2008 |
The interaction between particles and vascular endothelium in blood flow
|
Li, Xiaotong
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2009 |
The interplay between PEGylated nanoparticles and blood immune system
|
Guo, Chen
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2010 |
The intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders
|
Schindler, Kyra A.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2011 |
The in vivo drug delivery pattern of the organelle-targeting small molecules
|
Fang, Zhao
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2012 |
The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system
|
Jiang, Xin-Chi
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2013 |
The in vivo fate of polymeric micelles
|
Cai, Yifan
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2014 |
The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease
|
Schorn, Ian
|
|
2017
|
154-155 |
C |
p. 78-87
10 p.
|
artikel
|
| 2015 |
Themed issue: Extracellular vesicles in drug delivery and bioengineering
|
Fuhrmann, Gregor
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2016 |
Theme issue: In vitro mucus models
|
Kramer, Jessica R.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2017 |
The mesmiRizing complexity of microRNAs for striated muscle tissue engineering
|
Quattrocelli, Mattia
|
|
2015
|
154-155 |
C |
p. 37-52
16 p.
|
artikel
|
| 2018 |
The molecular circadian clock: From fundamental mechanisms to therapeutic promise in neurological disorders
|
Campbell-Galland, Adam
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2019 |
The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer
|
Weigelt, Britta
|
|
2014
|
154-155 |
C |
p. 42-51
10 p.
|
artikel
|
| 2020 |
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
|
Sockolosky, Jonathan T.
|
|
2015
|
154-155 |
C |
p. 109-124
16 p.
|
artikel
|
| 2021 |
The past, present and future in scaffold-based tendon treatments
|
Lomas, A.J.
|
|
2015
|
154-155 |
C |
p. 257-277
21 p.
|
artikel
|
| 2022 |
The past, present, and future of breast cancer models for nanomedicine development
|
Boix-Montesinos, Paz
|
|
|
154-155 |
C |
p. 306-330
|
artikel
|
| 2023 |
The potential for remodelling the tumour vasculature in glioblastoma
|
Brighi, Caterina
|
|
2018
|
154-155 |
C |
p. 49-61
|
artikel
|
| 2024 |
The potential role of nano- and micro-technology in the management of critical illnesses
|
Sadikot, Ruxana T.
|
|
2014
|
154-155 |
C |
p. 27-31
5 p.
|
artikel
|
| 2025 |
The potential to treat lung cancer via inhalation of repurposed drugs
|
Lee, Wing-Hin
|
|
2018
|
154-155 |
C |
p. 107-130
|
artikel
|
| 2026 |
The promising interplay between sonodynamic therapy and nanomedicine
|
Canaparo, Roberto
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2027 |
The quest for mechanically and biologically functional soft biomaterials via soft network composites
|
Bas, Onur
|
|
2018
|
154-155 |
C |
p. 214-234
|
artikel
|
| 2028 |
Theranostics applications of quantum dots in regenerative medicine, cancer medicine, and infectious diseases
|
Yukawa, Hiroshi
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2029 |
Therapeutic and delivery strategies of phytoconstituents for renal fibrosis
|
Xu, Huan
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2030 |
Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders
|
Sofias, Alexandros Marios
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2031 |
Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer
|
Raguraman, Rajeswari
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2032 |
Therapeutic aptamers in discovery, preclinical and clinical stages
|
Ismail, Said I.
|
|
2018
|
154-155 |
C |
p. 51-64
|
artikel
|
| 2033 |
Therapeutic cell encapsulation techniques and applications in diabetes
|
Steele, J.A.M.
|
|
2014
|
154-155 |
C |
p. 74-83
10 p.
|
artikel
|
| 2034 |
Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers
|
Chapa-Villarreal, Fabiola A.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2035 |
Therapeutic gene regulation using pyrrole–imidazole polyamides
|
Yu, Zutao
|
|
|
154-155 |
C |
p. 66-85
|
artikel
|
| 2036 |
Therapeutic genome editing in cardiovascular diseases
|
Nishiga, Masataka
|
|
|
154-155 |
C |
p. 147-157
|
artikel
|
| 2037 |
Therapeutic medications against diabetes: What we have and what we expect
|
Hu, Cheng
|
|
2019
|
154-155 |
C |
p. 3-15
|
artikel
|
| 2038 |
Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers
|
Tong, Lingying
|
|
2015
|
154-155 |
C |
p. 1-15
15 p.
|
artikel
|
| 2039 |
Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
|
Delbreil, Philippe
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2040 |
Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation
|
Melnyk, Tetiana
|
|
|
154-155 |
C |
p. 136-169
|
artikel
|
| 2041 |
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
|
Vartak, Tanwi
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2042 |
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
|
Cannito, Stefania
|
|
2017
|
154-155 |
C |
p. 57-84
|
artikel
|
| 2043 |
Therapeutic strategies for enhancing angiogenesis in wound healing
|
Veith, Austin P.
|
|
2019
|
154-155 |
C |
p. 97-125
|
artikel
|
| 2044 |
Therapeutic strategies to combat antibiotic resistance
|
Brooks, Benjamin D.
|
|
2014
|
154-155 |
C |
p. 14-27
14 p.
|
artikel
|
| 2045 |
Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders
|
Caspi, Michal
|
|
|
154-155 |
C |
p. 118-136
|
artikel
|
| 2046 |
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
|
Kumar, Virender
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2047 |
Thermally-triggered fabrication of cell sheets for tissue engineering and regenerative medicine
|
Takahashi, Hironobu
|
|
2019
|
154-155 |
C |
p. 276-292
|
artikel
|
| 2048 |
Thermoresponsive polymer nanocarriers for biomedical applications
|
Bordat, Alexandre
|
|
2019
|
154-155 |
C |
p. 167-192
|
artikel
|
| 2049 |
The RNA-binding protein HuR in human cancer: A friend or foe?
|
Wu, Xiaoqing
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2050 |
The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine
|
Pozzi, Sabina
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2051 |
The role of coagulome in the tumor immune microenvironment
|
Wahab, Riajul
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2052 |
The role of imaging in targeted delivery of nanomedicine for cancer therapy
|
Li, Puze
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2053 |
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
|
Hald Albertsen, Camilla
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2054 |
The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis
|
McAlister, Emma
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2055 |
The role of mucosal barriers in disease progression and transmission
|
Bustos, Nicole A.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2056 |
The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles
|
García-Díaz, María
|
|
2018
|
154-155 |
C |
p. 107-124
|
artikel
|
| 2057 |
The role of mucus in cell-based models used to screen mucosal drug delivery
|
Lechanteur, Anna
|
|
2018
|
154-155 |
C |
p. 50-63
|
artikel
|
| 2058 |
The role of mucus on drug transport and its potential to affect therapeutic outcomes
|
Murgia, Xabier
|
|
2018
|
154-155 |
C |
p. 82-97
|
artikel
|
| 2059 |
The role of RNA binding proteins in hepatocellular carcinoma
|
Zhang, Kai
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2060 |
The role of sex as a biological variable in the efficacy and toxicity of therapeutic nanomedicine
|
Sharifi, Shahriar
|
|
|
154-155 |
C |
p. 337-347
|
artikel
|
| 2061 |
The role of the cell surface glycocalyx in drug delivery to and through the endothelium
|
Fu, Lu
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2062 |
The role of the HBCU pipeline in diversifying the STEM workforce: Training the next generation of drug delivery researchers
|
Smith, Kalynda C.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2063 |
The significance of artificial intelligence in drug delivery system design
|
Hassanzadeh, Parichehr
|
|
|
154-155 |
C |
p. 169-190
|
artikel
|
| 2064 |
The solubility–permeability interplay and oral drug formulation design: Two heads are better than one
|
Dahan, Arik
|
|
2016
|
154-155 |
C |
p. 99-107
9 p.
|
artikel
|
| 2065 |
The sound of drug delivery: Optoacoustic imaging in pharmacology
|
Liu, Nian
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2066 |
The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy
|
Qin, Mengmeng
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2067 |
The state-of-play and future of antibody therapeutics
|
Elgundi, Zehra
|
|
2017
|
154-155 |
C |
p. 2-19
|
artikel
|
| 2068 |
The suprachoroidal space as a route of administration to the posterior segment of the eye
|
Chiang, Bryce
|
|
2018
|
154-155 |
C |
p. 58-66
|
artikel
|
| 2069 |
The tendon microenvironment: Engineered in vitro models to study cellular crosstalk
|
Gomez-Florit, Manuel
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2070 |
The 10th anniversary of MXenes: Challenges and prospects for their surface modification toward future biotechnological applications
|
Szuplewska, Aleksandra
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2071 |
The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives
|
Sun, Rui
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2072 |
The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging
|
Siddiqui, Sarmad
|
|
2017
|
154-155 |
C |
p. 3-23
21 p.
|
artikel
|
| 2073 |
The use of skin models in drug development
|
Mathes, Stephanie H.
|
|
2014
|
154-155 |
C |
p. 81-102
22 p.
|
artikel
|
| 2074 |
The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack
|
Guha, Abhishek
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2075 |
Thiolated polymers: Bioinspired polymers utilizing one of the most important bridging structures in nature
|
Leichner, Christina
|
|
|
154-155 |
C |
p. 191-221
|
artikel
|
| 2076 |
Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment
|
Monaghan, Michael G.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2077 |
Three-dimensional cardiac tissue fabrication based on cell sheet technology
|
Masuda, Shinako
|
|
2016
|
154-155 |
C |
p. 103-109
7 p.
|
artikel
|
| 2078 |
Three-dimensional cell culture technique and pathophysiology
|
Matsusaki, Michiya
|
|
2014
|
154-155 |
C |
p. 95-103
9 p.
|
artikel
|
| 2079 |
Three-dimensional modeling of ovarian cancer
|
White, Erin A.
|
|
2014
|
154-155 |
C |
p. 184-192
9 p.
|
artikel
|
| 2080 |
Three significant highlights of controlled drug delivery over the past 55 years: PEGylation, ADCs, and EPR
|
Hoffman, Allan S.
|
|
|
154-155 |
C |
p. 2-3
|
artikel
|
| 2081 |
Tip-enhanced Raman scattering—Targeting structure-specific surface characterization for biomedical samples
|
Sharma, Gaurav
|
|
2015
|
154-155 |
C |
p. 42-56
15 p.
|
artikel
|
| 2082 |
Tissue engineered buccal mucosa for urethroplasty: Progress and future directions
|
Osman, N.I.
|
|
2015
|
154-155 |
C |
p. 69-76
8 p.
|
artikel
|
| 2083 |
Tissue-engineered 3D tumor angiogenesis models: Potential technologies for anti-cancer drug discovery
|
Chwalek, Karolina
|
|
2014
|
154-155 |
C |
p. 30-39
10 p.
|
artikel
|
| 2084 |
Tissue-engineered kidney disease models
|
DesRochers, Teresa M.
|
|
2014
|
154-155 |
C |
p. 67-80
14 p.
|
artikel
|
| 2085 |
Tissue engineered models of healthy and malignant human bone marrow
|
Chramiec, Alan
|
|
2019
|
154-155 |
C |
p. 78-92
|
artikel
|
| 2086 |
Tissue engineering and regenerative medicine: bench to bedside in urology
|
Damaser, Margot S.
|
|
2015
|
154-155 |
C |
p. v-vii
nvt p.
|
artikel
|
| 2087 |
Tissue engineering in urothelium regeneration
|
Vaegler, Martin
|
|
2015
|
154-155 |
C |
p. 64-68
5 p.
|
artikel
|
| 2088 |
Tissue engineering strategies to study cartilage development, degeneration and regeneration
|
Bhattacharjee, Maumita
|
|
2015
|
154-155 |
C |
p. 107-122
16 p.
|
artikel
|
| 2089 |
Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening
|
Kurokawa, Yosuke K.
|
|
2016
|
154-155 |
C |
p. 225-233
9 p.
|
artikel
|
| 2090 |
Tools for computational design and high-throughput screening of therapeutic enzymes
|
Vasina, Michal
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2091 |
Top-down fabrication of shape-controlled, monodisperse nanoparticles for biomedical applications
|
Fu, Xinxin
|
|
2018
|
154-155 |
C |
p. 169-187
|
artikel
|
| 2092 |
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
|
Shi, Da
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2093 |
Topical drug delivery: History, percutaneous absorption, and product development
|
Roberts, Michael S.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2094 |
Topical treatments for skin cancer
|
Cullen, Jason K.
|
|
|
154-155 |
C |
p. 54-64
|
artikel
|
| 2095 |
Topical treatment strategies to manipulate human skin pigmentation
|
Rachmin, Inbal
|
|
|
154-155 |
C |
p. 65-71
|
artikel
|
| 2096 |
Topology dependent modification of layered double hydroxide for therapeutic and diagnostic platform
|
Kim, Tae-Hyun
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2097 |
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
|
Maeda, Hiroshi
|
|
2015
|
154-155 |
C |
p. 3-6
4 p.
|
artikel
|
| 2098 |
Toward closed-loop drug delivery: Integrating wearable technologies with transdermal drug delivery systems
|
Manikkath, Jyothsna
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2099 |
Toward rational vaccine engineering
|
Vishweshwaraiah, Yashavantha L.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2100 |
Towards airway microbiome engineering for improving respiratory health
|
Hern, Kelsey E.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2101 |
Towards artificial intelligence-enabled extracellular vesicle precision drug delivery
|
Greenberg, Zachary F.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2102 |
Towards chamber specific heart-on-a-chip for drug testing applications
|
Zhao, Yimu
|
|
|
154-155 |
C |
p. 60-76
|
artikel
|
| 2103 |
Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound
|
Schoen Jr, Scott
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2104 |
Towards Enhancing Skin Drug Delivery
|
Gu, Zhen
|
|
|
154-155 |
C |
p. 1-2
|
artikel
|
| 2105 |
Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool
|
Qi, Jianping
|
|
|
154-155 |
C |
p. 206-225
|
artikel
|
| 2106 |
Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design
|
Mathias, Neil
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2107 |
Towards single cell encapsulation for precision biology and medicine
|
Gupta, Prerak
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2108 |
Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy
|
Zhan, Changyou
|
|
2015
|
154-155 |
C |
p. 101-118
18 p.
|
artikel
|
| 2109 |
Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health
|
Zhang, Jing
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2110 |
Trans-corneal drug delivery strategies in the treatment of ocular diseases
|
Li, Liping
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2111 |
Transcytosis-enabled active extravasation of tumor nanomedicine
|
Zhou, Quan
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2112 |
Transdermal drug delivery via microneedles to mediate wound microenvironment
|
Mo, Ran
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2113 |
Transdermal immunomodulation: Principles, advances and perspectives
|
Zhao, Zongmin
|
|
|
154-155 |
C |
p. 3-19
|
artikel
|
| 2114 |
Transflammation: Innate immune signaling in nuclear reprogramming
|
Meng, Shu
|
|
2017
|
154-155 |
C |
p. 133-141
|
artikel
|
| 2115 |
Transflammation in tissue regeneration and response to injury: How cell-autonomous inflammatory signaling mediates cell plasticity
|
Cooke, John P.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2116 |
Transformable vesicles for cancer immunotherapy
|
Wang, Shuang
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2117 |
Transforming nanomedicine manufacturing toward Quality by Design and microfluidics
|
Colombo, Stefano
|
|
2018
|
154-155 |
C |
p. 115-131
|
artikel
|
| 2118 |
Translating a radiolabeled imaging agent to the clinic
|
Griffiths, Gary L.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2119 |
Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
|
Heinrich, Marcel A.
|
|
|
154-155 |
C |
p. 265-293
|
artikel
|
| 2120 |
Translating 3D printed pharmaceuticals: From hype to real-world clinical applications
|
Seoane-Viaño, Iria
|
|
|
154-155 |
C |
p. 553-575
|
artikel
|
| 2121 |
Translating ultrasound-mediated drug delivery technologies for CNS applications
|
Perolina, Ederlyn
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2122 |
Translational challenges in advancing regenerative therapy for treating neurological disorders using nanotechnology
|
Nemeth, C.L.
|
|
|
154-155 |
C |
p. 60-67
|
artikel
|
| 2123 |
Translational considerations in nanomedicine: The oncology perspective
|
Gabizon, Alberto A.
|
|
|
154-155 |
C |
p. 140-157
|
artikel
|
| 2124 |
Translational drug delivery: Time to be Frank for future success
|
Venditto, Vincent J.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2125 |
Translational oncotargets for immunotherapy: From pet dogs to humans
|
Mestrinho, Lisa A.
|
|
|
154-155 |
C |
p. 296-313
|
artikel
|
| 2126 |
Translation of cell therapies to treat autoimmune disorders
|
Mehta, Jinal M.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2127 |
Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic
|
Lam, Jenny K.W.
|
|
|
154-155 |
C |
p. 234-243
|
artikel
|
| 2128 |
Treating allergies via skin – Recent advances in cutaneous allergen immunotherapy
|
Nesovic, Lazar D.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2129 |
Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory
|
Ke, Weina
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2130 |
Trends in versatile 2D (sheet/paper-like) nanomaterials for biomedical applications
|
Kankala, Ranjith Kumar
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2131 |
Triggering antitumoural drug release and gene expression by magnetic hyperthermia
|
Moros, María
|
|
2019
|
154-155 |
C |
p. 326-343
|
artikel
|
| 2132 |
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery
|
Kyu Shim, Man
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2133 |
Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery
|
Jiang, Jipeng
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2134 |
Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma
|
Liu, Yanhong
|
|
|
154-155 |
C |
p. 80-103
|
artikel
|
| 2135 |
Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment
|
Yang, Yu
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2136 |
Tumor-on-chip modeling of organ-specific cancer and metastasis
|
Del Piccolo, Nuala
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2137 |
Tumor penetrating peptides for improved drug delivery
|
Ruoslahti, Erkki
|
|
2017
|
154-155 |
C |
p. 3-12
10 p.
|
artikel
|
| 2138 |
Tumor-targeting peptides from combinatorial libraries
|
Liu, Ruiwu
|
|
2017
|
154-155 |
C |
p. 13-37
25 p.
|
artikel
|
| 2139 |
Tumor targeting via EPR: Strategies to enhance patient responses
|
Golombek, Susanne K.
|
|
2018
|
154-155 |
C |
p. 17-38
|
artikel
|
| 2140 |
Tumour extravasation of nanomedicine: The EPR and alternative pathways
|
Shen, Youqing
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2141 |
Turning Nature’s own processes into design strategies for living bone implant biomanufacturing: a decade of Developmental Engineering
|
Papantoniou, Ioannis
|
|
|
154-155 |
C |
p. 22-39
|
artikel
|
| 2142 |
Two-Dimensional Nanomaterial-based catalytic Medicine: Theories, advanced catalyst and system design
|
Zeng, Weiwei
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2143 |
Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy
|
Wu, Miaomiao
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2144 |
Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives
|
Scomparin, Anna
|
|
2017
|
154-155 |
C |
p. 52-64
|
artikel
|
| 2145 |
Type 1 diabetes and engineering enhanced islet transplantation
|
Jeyagaran, Abiramy
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2146 |
Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook
|
Singh, Neetu
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2147 |
Ultrasonic particles: An approach for targeted gene delivery
|
Walsh, Aidan P.G.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2148 |
Ultrasound-activatable and skin-associated minimally invasive microdevices for smart drug delivery and diagnosis
|
Zeng, Qi
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2149 |
Ultrasound activated probe for disease imaging and therapy In-Vivo
|
Liu, Xing
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2150 |
Ultrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicine
|
Snipstad, Sofie
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2151 |
Ultrasound assisted drug delivery
|
Moonen, Chrit
|
|
2014
|
154-155 |
C |
p. 1-2
2 p.
|
artikel
|
| 2152 |
Ultrasound induced cancer immunotherapy
|
Unga, Johan
|
|
2014
|
154-155 |
C |
p. 144-153
10 p.
|
artikel
|
| 2153 |
Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system
|
Aryal, Muna
|
|
2014
|
154-155 |
C |
p. 94-109
16 p.
|
artikel
|
| 2154 |
Ultrasound-mediated blood–brain barrier opening: An effective drug delivery system for theranostics of brain diseases
|
Wang, Jieqiong
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2155 |
Ultrasound mediated transdermal drug delivery
|
Azagury, Aharon
|
|
2014
|
154-155 |
C |
p. 127-143
17 p.
|
artikel
|
| 2156 |
Ultrasound-nanovesicles interplay for theranostics
|
Liu, Jingyi
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2157 |
Ultrasound-responsive microbubbles and nanodroplets: A pathway to targeted drug delivery
|
Shakya, Gazendra
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2158 |
Ultrasound robotics for precision therapy
|
Del Campo Fonseca, Alexia
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2159 |
Ultrasound triggered organic mechanoluminescence materials
|
Wang, Wenliang
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2160 |
Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models
|
Ringquist, Rachel
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2161 |
Understanding interactions between biomolecules and two-dimensional nanomaterials using in silico microscopes
|
Chen, Serena H.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2162 |
Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy
|
Phyo, Pyae
|
|
|
154-155 |
C |
p. 1-29
|
artikel
|
| 2163 |
Understanding the bidirectional interactions between two-dimensional materials, microorganisms, and the immune system
|
Peng, Guotao
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2164 |
Understanding the Challenge of Beyond-Rule-of-5 Compounds
|
Bergström, Christel A.S.
|
|
2016
|
154-155 |
C |
p. 1-5
5 p.
|
artikel
|
| 2165 |
Understanding the interactions between inorganic-based nanomaterials and biological membranes
|
Kang, Yiyuan
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2166 |
Understanding the neurovascular unit at multiple scales: Advantages and limitations of multi-photon and functional ultrasound imaging
|
Urban, Alan
|
|
2017
|
154-155 |
C |
p. 73-100
|
artikel
|
| 2167 |
Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms
|
Lentacker, I.
|
|
2014
|
154-155 |
C |
p. 49-64
16 p.
|
artikel
|
| 2168 |
Unignored intracellular journey and biomedical applications of extracellular vesicles
|
Zhao, Jiuhong
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2169 |
Unintended and in situ amorphisation of pharmaceuticals
|
Priemel, P.A.
|
|
2016
|
154-155 |
C |
p. 126-132
7 p.
|
artikel
|
| 2170 |
Unintended effects of drug carriers: Big issues of small particles
|
Parhiz, Hamideh
|
|
2018
|
154-155 |
C |
p. 90-112
|
artikel
|
| 2171 |
Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms
|
Williams, Hywel D.
|
|
2019
|
154-155 |
C |
p. 75-90
|
artikel
|
| 2172 |
Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques
|
Pegoraro, Camilla
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2173 |
Unraveling the in vivo fate and cellular pharmacokinetics of drug nanocarriers
|
Wu, Wei
|
|
|
154-155 |
C |
p. 1-2
|
artikel
|
| 2174 |
Upconversion nanomaterials and delivery systems for smart photonic medicines and healthcare devices
|
Lee, Gibum
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2175 |
Up-to-date molecular medicine strategies for management of ocular surface neovascularization
|
Yang, Yunlong
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2176 |
Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
|
Meng, Huan
|
|
2018
|
154-155 |
C |
p. 50-57
|
artikel
|
| 2177 |
Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections
|
Abedon, Stephen T.
|
|
2019
|
154-155 |
C |
p. 18-39
|
artikel
|
| 2178 |
Use of plant viruses and virus-like particles for the creation of novel vaccines
|
Balke, Ina
|
|
2019
|
154-155 |
C |
p. 119-129
|
artikel
|
| 2179 |
Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells
|
Tay, Felix Chang
|
|
2015
|
154-155 |
C |
p. 117-127
11 p.
|
artikel
|
| 2180 |
Using bugs as drugs: Administration of bacteria-related microbes to fight cancer
|
Wang, Jiawei
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2181 |
Using skin for drug delivery and diagnosis in the critically ill
|
Liu, Xin
|
|
2014
|
154-155 |
C |
p. 40-49
10 p.
|
artikel
|
| 2182 |
Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting
|
Fabre, Kristin M.
|
|
2019
|
154-155 |
C |
p. 129-135
|
artikel
|
| 2183 |
Vaccine delivery systems toward lymph nodes
|
Ding, Yingyue
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2184 |
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
|
Batty, Cole J.
|
|
|
154-155 |
C |
p. 168-189
|
artikel
|
| 2185 |
Vaccines for immune tolerance against autoimmune disease
|
Kim, April
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2186 |
Vaginal delivery of vaccines
|
VanBenschoten, Hannah M.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2187 |
Vaginal drug delivery approaches for localized management of cervical cancer
|
Wang, Xue
|
|
|
154-155 |
C |
p. 114-126
|
artikel
|
| 2188 |
Vaginal drug distribution modeling
|
Katz, David F.
|
|
2015
|
154-155 |
C |
p. 2-13
12 p.
|
artikel
|
| 2189 |
Vaginal gene therapy
|
Rodríguez-Gascón, Alicia
|
|
2015
|
154-155 |
C |
p. 71-83
13 p.
|
artikel
|
| 2190 |
Variations in gastrointestinal lipases, pH and bile acid levels with food intake, age and diseases: Possible impact on oral lipid-based drug delivery systems
|
Amara, Sawsan
|
|
2019
|
154-155 |
C |
p. 3-15
|
artikel
|
| 2191 |
Vascularization strategies of engineered tissues and their application in cardiac regeneration
|
Sun, Xuetao
|
|
2016
|
154-155 |
C |
p. 183-194
12 p.
|
artikel
|
| 2192 |
Vascular targeting of nanoparticles for molecular imaging of diseased endothelium
|
Atukorale, Prabhani U.
|
|
2017
|
154-155 |
C |
p. 141-156
16 p.
|
artikel
|
| 2193 |
Vasculature organotropism in drug delivery
|
Amruta, A
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2194 |
Versatility on demand – The case for semi-solid micro-extrusion in pharmaceutics
|
Rahman, Jhinuk
|
|
|
154-155 |
C |
p. 104-126
|
artikel
|
| 2195 |
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
|
Chung, Young Hun
|
|
|
154-155 |
C |
p. 214-235
|
artikel
|
| 2196 |
Virus integration and genome influence in approaches to stem cell based therapy for andro-urology
|
Li, Longkun
|
|
2015
|
154-155 |
C |
p. 12-21
10 p.
|
artikel
|
| 2197 |
Visualizing and quantifying antimicrobial drug distribution in tissue
|
Kuzma, Benjamin A.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2198 |
Visualizing kinetics of diffusional penetration in tissues using OCT-based strain imaging
|
Alexandrovskaya, Y.M.
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2199 |
When barriers ignore the “rule-of-five”
|
Krämer, Stefanie D.
|
|
2016
|
154-155 |
C |
p. 62-74
13 p.
|
artikel
|
| 2200 |
When imaging meets size-transformable nanosystems
|
Zhou, Yang
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2201 |
When liposomes met antibodies: Drug delivery and beyond
|
Di, Jiaxing
|
|
|
154-155 |
C |
p. 151-162
|
artikel
|
| 2202 |
Why nanoparticles prefer liver macrophage cell uptake in vivo
|
Ngo, Wayne
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2203 |
Why traditional herbal medicine promotes wound healing: Research from immune response, wound microbiome to controlled delivery
|
Xu, Zeyu
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2204 |
Will dapivirine redeem the promises of anti-HIV microbicides? Overview of product design and clinical testing
|
das Neves, José
|
|
|
154-155 |
C |
p. 20-32
|
artikel
|
| 2205 |
Women-specific routes of administration for drugs: A critical overview
|
das Neves, José
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2206 |
Women’s preferences and acceptance for different drug delivery routes and products
|
Palmeira-de-Oliveira, Rita
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2207 |
Wound healing and fibrosis – State of play
|
Korntner, Stefanie
|
|
2019
|
154-155 |
C |
p. 1-2
|
artikel
|
| 2208 |
Wound healing and scar wars
|
Pugliese, Eugenia
|
|
|
154-155 |
C |
p. 1-3
|
artikel
|
| 2209 |
Wound healing in the eye: Therapeutic prospects
|
Ziaei, Mohammed
|
|
2018
|
154-155 |
C |
p. 162-176
|
artikel
|
| 2210 |
Wound healing in urology
|
Ninan, Neethu
|
|
2015
|
154-155 |
C |
p. 93-105
13 p.
|
artikel
|
| 2211 |
Wound healing related agents: Ongoing research and perspectives
|
Kaplani, Konstantina
|
|
|
154-155 |
C |
p. 242-253
|
artikel
|
| 2212 |
Xenobiotic transporters and kidney injury
|
George, Blessy
|
|
2017
|
154-155 |
C |
p. 73-91
19 p.
|
artikel
|
| 2213 |
50years of oral lipid-based formulations: Provenance, progress and future perspectives
|
Feeney, Orlagh M.
|
|
2016
|
154-155 |
C |
p. 167-194
28 p.
|
artikel
|
| 2214 |
Zebrafish as a preclinical in vivo screening model for nanomedicines
|
Sieber, Sandro
|
|
|
154-155 |
C |
p. 152-168
|
artikel
|
| 2215 |
Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development
|
Androuin, Alexandre
|
|
|
154-155 |
C |
p.
|
artikel
|
| 2216 |
Zero-dimensional, one-dimensional, two-dimensional and three-dimensional biomaterials for cell fate regulation
|
Zhang, Can
|
|
2018
|
154-155 |
C |
p. 33-56
|
artikel
|
Tijdschrift beschrijving